LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-2-oxo-tetrahydrofuranyl)-carbothioic acid ester,...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-(cyclic amino) aryl...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-acyl-17&agr;-propynyl-11&bgr;-arylsteroids and their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17&bgr;-amino and hydroxylamino-11&bgr;-arylsteroids and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(3-furyl)-5.beta., 14.beta.-androstane derivatives active on

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-(4-pyridazinyl) -5.beta., 14.beta.-androstane derivatives act

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-.alpha.-acyl steroids which inhibit 5-.alpha.-reductase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-.alpha.and 17-.beta.substituted acyl-3-carboxy-3,5-dienes and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-aryl and 17-heterocyclyl-14.beta.-5.alpha.-androstane, andros

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-Aryl and 17-heterocyclyl-5.beta.,14.beta.-androstane derivati

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-aryl linker derivatised estrogen 3-sulphamates as...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-aryl-substituted steroidal compounds active on the cardiovasc

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-azolyl steroids useful as androgen synthesis inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-Azolyl steroids useful as androgren synthesis inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-carbamoyloxy cortisol derivatives as selective...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-Difluoromethylene-estratrienes

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-halogenated 19-nor steroids, method and intermediates for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

17-halomethylene estratrienes